Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia

Clinical trial NCT05282108 · RECRUITING

Trial details

NCT number: NCT05282108
Sponsor: Hikma Pharmaceuticals LLC
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia

Start date: 2022-07-20
Primary completion: 2026-08-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.